Rosuvastatin Tablet, Film Coated
Product Images NDC 70518-4303

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 70518-4303). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a prescription medication called Rosuvastatin, in the form of 10 mg tablets. The package contains 90 tablets and should be stored at 20-25°C (58-77°F). The medication is manufactured by ScieGen in Hauppauge, NY, and repackaged by RemedyRepack Inc. It is important to keep this medication out of the reach of children. For directions on use, refer to the package insert.*
FDA Label Image

Figure-01 (Figure 1)

Figure-01 (Figure 1)
This text appears to be a tabular data presenting results of a study or trial comparing two groups (RSV and Placebo) over a period of time in terms of the number at risk and the survival years. The RSV group has significantly different values compared to the placebo group based on a P-value of less than 0.001. The text also includes confidence intervals for some measurements.*
FDA Label Image

Figure-02 (Figure 2)

Figure-02 (Figure 2)
This is a statistical comparison between two groups receiving different doses of Rosuvastatin (20 mg) and Placebo (20 mg) in a study with 8901 participants. The text includes data on various endpoints such as the primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, and hospitalized unstable angina. The Hazard Ratios (HR) with confidence intervals and p-values are provided for each endpoint, showcasing the differences in event rates between the two groups. Additionally, the study includes information on the definition of cardiovascular death and presents event rates per 1 year for better understanding of the outcomes.*
FDA Label Image

Figure-02 (Figure 3)

Figure-02 (Figure 3)
FDA Label Image

Structural Formula (Rosuvastatin Str)

Structural Formula (Rosuvastatin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.